Cargando…
A nomogram based on (18)F-fluorodeoxyglucose PET/CT and clinical features to predict epidermal growth factor receptor mutation status in patients with lung adenocarcinoma
BACKGROUND: Identifying epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma (LADC) is vital for treatment decision-making. This study aimed to establish a convenient and noninvasive nomogram prediction model based on (18)F-fluorodeoxyglucose positron emission tomography/computed...
Autores principales: | Guo, Yue, Zhu, Hui, Chen, Congxia, Li, Xu, Liu, Fugeng, Yao, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622444/ https://www.ncbi.nlm.nih.gov/pubmed/36330175 http://dx.doi.org/10.21037/qims-22-248 |
Ejemplares similares
-
Combination of (18)F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Li, Shen, et al.
Publicado: (2022) -
The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011) -
Inflammatory Pseudotumor in the Mediastinum: Imaging with (18)F-Fluorodeoxyglucose PET/CT
por: Yoon, Seok-Ho, et al.
Publicado: (2013) -
(18)F-Fluorodeoxyglucose PET/CT in a Patient with Esophageal and Genital Leiomyomatosis
por: An, Young-Sil, et al.
Publicado: (2009) -
Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT
por: Seshadri, Nagabhushan, et al.
Publicado: (2010)